CBLL
CBLL
US15678C1027
CeriBell, Inc.
Loading chart...

Company Profile

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Latest News

Related stocks

QDEL
QDEL • United States
QuidelOrtho Corporation
13.42 USD
920.28M USD 1Y -55.5%
BVS
BVS • United States
Bioventus Inc.
13.07 USD
892.41M USD 1Y +87.7%
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
SIBN
SIBN • United States
SI-BONE, Inc.
19.37 USD
859.05M USD 1Y +24%
AHCO
AHCO • United States
AdaptHealth Corp.
6.06 USD
824.49M USD 1Y -32.3%
ENOV
ENOV • United States
Enovis Corporation
17.69 USD
1.02B USD 1Y -45.2%
LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
IART
IART • United States
Integra LifeSciences Holdings C
13.44 USD
1.05B USD 1Y -9.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
65.4% p.a.
Max Drawdown (3Y)
-63.9%
Sharpe Ratio (3Y)
-0.10
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende